Land: New Zealand
Språk: engelsk
Kilde: Medsafe (Medicines Safety Authority)
Ciprofloxacin hydrochloride 582mg equivalent to ciprofloxacin 500 mg;
Ipca Pharma (NZ) Pty Limited
Ciprofloxacin hydrochloride 582 mg (equivalent to ciprofloxacin 500 mg)
500 mg
Film coated tablet
Active: Ciprofloxacin hydrochloride 582mg equivalent to ciprofloxacin 500 mg Excipient: Colloidal silicon dioxide Hypromellose Macrogol 4000 Magnesium stearate Maize starch Microcrystalline cellulose Purified talc Purified water Sodium starch glycolate Titanium dioxide
Blister pack, PVC/Al. 7 Tablets, 7 tablets
Prescription
Prescription
Dr Reddy's Laboratories Limited
For complicated urinary tract infections or pyelonephritis due to E.coli in paediatric patients aged 1-17 years. The risk-benefit assessment indicates that administration of ciprofloxacin to paediatric patients is appropriate. Treatment should only be initiated after careful benefit/risk evaluation, due to possible adverse events related to joints/surrounding tissues. The use of ciprofloxacin for other indications is not recommended in children.
Package - Contents - Shelf Life: Blister pack, PVC/Al. 7 Tablets - 7 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al. 10 Tablets - 10 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al. 14 Tablets - 14 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al. 20 Tablets - 20 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al. 28 Tablets - 28 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al. 56 Tablets - 56 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al. 100 Tablets - 100 tablets - 36 months from date of manufacture stored at or below 25°C
2004-07-15